Monitoring asthma in childhood: Lung function, bronchial responsiveness and inflammation

European Respiratory Review

Volumn 24, Issue 136, 2015, Pages 204-215

  Moeller, Alexander ^a   Carlsen, Kai Hakon ^b   Sly, Peter D ^c   Baraldi, Eugenio ^d   Piacentini, Giorgio ^e   Pavord, Ian ^f   Lex, Christiane ^g   Saglani, Sejal ^h   Brand, Paul L P ^i,j   Eber, Ernst ^k   Frischer, Thomas ^l   Hedlin, Gunilla ^m   Kulkarni, Neeta ⁿ   Lødrup Carlsen, Karin C ^b,u   Mäkelä, Mika J ^o   Mantzouranis, Eva ^p   Pijnenburg, Mariëlle W ^q   Price, David ^r   Rottier, Bart L ^j   Szefler, Stanley J ^s   Turner, Steve ^r   Wooler, Edwina ^t   more..

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d UNIVERSITY OF PADOVA   (Italy)

^e UNIVERSITY OF VERONA   (Italy)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^h NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

ⁱ ISALA HOSPITAL   (Netherlands)

^j UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^k MEDICAL UNIVERSITY OF GRAZ   (Austria)

^l WILHELMINEN HOSPITAL   (Austria)

^m KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

ⁿ UNIVERSITY OF LEICESTER   (United Kingdom)

^o HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^p UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^q SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^r UNIVERSITY OF ABERDEEN   (United Kingdom)

^s UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^t ROYAL ALEXANDRA CHILDREN S HOSPITAL   (United Kingdom)

^u UNIVERSITY OF OSLO   (Norway)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; MONTELUKAST; NITRIC OXIDE; ANTIASTHMATIC AGENT; AUTACOID;

AIRWAY RESISTANCE; ARTICLE; ASTHMA; ASYMPTOMATIC DISEASE; ATOPY; BODY PLETHYSMOGRAPHY; BRONCHITIS; BRONCHODILATATION; BRONCHUS REACTIVITY; CHILDHOOD DISEASE; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; DISEASE EXACERBATION; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; FORCED OSCILLATION TECHNIQUE; FORCED VITAL CAPACITY; HUMAN; IMPULSE OSCILLOMETRY; INTERRUPTER RESISTANCE; LONGITUDINAL STUDY; LUNG CLEARANCE; LUNG FLOW VOLUME CURVE; LUNG FUNCTION; LUNG FUNCTION TEST; MAXIMAL EXPIRATORY FLOW; OSCILLATION; PATIENT MONITORING; RESPIROMETRY; RISK FACTOR; SPUTUM ANALYSIS; WHEEZING; AGE; BRONCHIAL HYPERREACTIVITY; BRONCHOCONSTRICTION; CHILD; DECISION SUPPORT SYSTEM; DRUG EFFECTS; IMMUNOLOGY; INFANT; LUNG; PATHOPHYSIOLOGY; PNEUMONIA; PREDICTIVE VALUE; PRESCHOOL CHILD; TREATMENT OUTCOME;

AGE FACTORS; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHOCONSTRICTION; CHILD; CHILD, PRESCHOOL; DECISION SUPPORT TECHNIQUES; HUMANS; INFANT; INFLAMMATION MEDIATORS; LUNG; PNEUMONIA; PREDICTIVE VALUE OF TESTS; RESPIRATORY FUNCTION TESTS; RISK FACTORS; TREATMENT OUTCOME;

EID: 84965094861     PISSN: 09059180     EISSN: 16000617     Source Type: Journal    
DOI: 10.1183/16000617.00003914     Document Type: Article

References (147)

1. 1 Pijnenburg MW, Baraldi E, Brand PLP, et al. Monitoring asthma in children. Eur Respir J 2015; 45: 906–925.
2. 2 Lødrup Carlsen KC, Pijnenburg MW. Monitoring asthma in childhood. Eur Respir Rev 2015; 24: 178–186.
3. 3 Brand PLP, Mäkelä MJ, Szefler SJ, et al. Monitoring asthma in childhood: symptoms, exacerbations and quality of life. Eur Respir Rev 2015; 24: 187–193.
4. 4 Rottier BL, Eber E, Hedlin G, et al. Monitoring asthma in childhood: management-related issues. Eur Respir Rev 2015; 24: 194–203.
5. 5 Rietveld S, Everaerd W. Perceptions of asthma by adolescents at home. Chest 2000; 117: 434–439.
6. 6 Clough JB, Holgate ST. Episodes of respiratory morbidity in children with cough and wheeze. Am J Respir Crit Care Med 1994; 150: 48–53.
7. 7 Bijl-Hofland ID, Cloosterman SG, Folgering HT, et al. Relation of the perception of airway obstruction to the severity of asthma. Thorax 1999; 54: 15–19.
8. 8 Grant EN, Moy JN, Turner-Roan K, et al. Asthma care practices, perceptions, and beliefs of Chicago-area primary-care physicians. Chicago Asthma Surveillance Initiative Project Team. Chest 1999; 116: Suppl. 1, 145S–154S.
9. Finkelstein JA, Lozano P, Shulruff R, et al. Self-reported physician practices for children with asthma: are national guidelines followed? Pediatrics 2000; 106: Suppl., 886–896.
10. 10 García-Marcos L, Castro-Rodríguez JA, Montaner AE, et al. The use of spirometers and peak flow meters in the diagnosis and management of asthma among Spanish pediatricians. Results from the TRAP study. Pediatr Allergy Immunol 2004; 15: 365–371.
11. 11 Dombkowski KJ, Hassan F, Wasilevich EA, et al. Spirometry use among pediatric primary care physicians. Pediatrics 2010; 126: 682–687.
12. 12 Liu AH. Biomarkers and childhood asthma: improving control today and tomorrow. Allergy Asthma Proc 2005; 26: 249–254.
13. 13 Sears MR, Greene JM, Willan AR, et al. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med 2003; 349: 1414–1422.
14. 14 Fuhlbrigge AL, Kitch BT, Paltiel AD, et al. FEV1 is associated with risk of asthma attacks in a pediatric population. J Allergy Clin Immunol 2001; 107: 61–67.
15. National Asthma Education and Prevention Program. National Asthma Education and Prevention Program. Expert panel report: guidelines for the diagnosis and management of asthma update on selected topics –2002. J Allergy Clin Immunol 2002; 110: Suppl., S141–S219.
16. National Asthma Education and Prevention Program. Expert panel report 3 (EPR-3): guidelines for the diagnosis and management of asthma –summary report 2007. J Allergy Clin Immunol 2007; 120: Suppl., S94–S138.
17. 17 Vonk JM, Postma DS, Boezen HM, et al. Childhood factors associated with asthma remission after 30 year follow up. Thorax 2004; 59: 925–929.
18. 18 Paull K, Covar R, Jain N, et al. Do NHLBI lung function criteria apply to children? A cross-sectional evaluation of childhood asthma at National Jewish Medical and Research Center, 1999–2002. Pediatr Pulmonol 2005; 39: 311–317.
19. 19 Bacharier LB, Strunk RC, Mauger D, et al. Classifying asthma severity in children: mismatch between symptoms, medication use, and lung function. Am J Respir Crit Care Med 2004; 170: 426–432.
20. 20 Sly PD, Landau LI, Weymouth R. Home recording of peak expiratory flow rates and perception of asthma. Am J Dis Child 1985; 139: 479–482.
21. 21 Brouwer AF, Roorda RJ, Brand PL. Home spirometry and asthma severity in children. Eur Respir J 2006; 28: 1131–1137.
22. 22 Wensley DC, Silverman M. The quality of home spirometry in school children with asthma. Thorax 2001; 56: 183–185.
23. 23 Thompson R, Delfino RJ, Tjoa T, et al. Evaluation of daily home spirometry for school children with asthma: new insights. Pediatr Pulmonol 2006; 41: 819–828.
24. 24 Deschildre A, Béghin L, Salleron J, et al. Home telemonitoring (forced expiratory volume in 1 s) in children with severe asthma does not reduce exacerbations. Eur Respir J 2012; 39: 290–296.
25. 25 Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948–968.
26. 26 Sharma S, Litonjua AA, Tantisira KG, et al. Clinical predictors and outcomes of consistent bronchodilator response in the childhood asthma management program. J Allergy Clin Immunol 2008; 122: 921–928.
27. 27 Holt EW, Cook EF, Covar RA, et al. Identifying the components of asthma health status in children with mild to moderate asthma. J Allergy Clin Immunol 2008; 121: 1175–1180.
28. 28 Tantisira KG, Fuhlbrigge AL, Tonascia J, et al. Bronchodilation and bronchoconstriction: predictors of future lung function in childhood asthma. J Allergy Clin Immunol 2006; 117: 1264–1271.
29. 29 Covar RA, Szefler SJ, Martin RJ, et al. Relations between exhaled nitric oxide and measures of disease activity among children with mild-to-moderate asthma. J Pediatr 2003; 142: 469–475.
30. 30 Strunk RC, Szefler SJ, Phillips BR, et al. Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children. J Allergy Clin Immunol 2003; 112: 883–892.
31. 31 Goleva E, Hauk PJ, Boguniewicz J, et al. Airway remodeling and lack of bronchodilator response in steroid-resistant asthma. J Allergy Clin Immunol 2007; 120: 1065–1072.
32. 32 Thamrin C, Gangell CL, Udomittipong K, et al. Assessment of bronchodilator responsiveness in preschool children using forced oscillations. Thorax 2007; 62: 814–819.
33. 33 Brouwer AF, Roorda RJ, Duiverman EJ, et al. Reference values for peak flow and FEV1 variation in healthy schoolchildren using home spirometry. Eur Respir J 2008; 32: 1262–1268.
34. 34 Quackenboss JJ, Lebowitz MD, Krzyzanowski M. The normal range of diurnal changes in peak expiratory flow rates. Relationship to symptoms and respiratory disease. Am Rev Respir Dis 1991; 143: 323–330.
35. 35 Brand PL, Roorda RJ. Usefulness of monitoring lung function in asthma. Arch Dis Child 2003; 88: 1021–1025.
36. 36 Kamps AW, Roorda RJ, Brand PL. Peak flow diaries in childhood asthma are unreliable. Thorax 2001; 56: 180–182.
37. 37 Yoos HL, Kitzman H, McMullen A, et al. Symptom monitoring in childhood asthma: a randomized clinical trial comparing peak expiratory flow rate with symptom monitoring. Ann Allergy Asthma Immunol 2002; 88: 283–291.
38. 38 Burkhart PV, Rayens MK, Revelette WR, et al. Improved health outcomes with peak flow monitoring for children with asthma. J Asthma 2007; 44: 137–142.
39. 39 Wensley D, Silverman M. Peak flow monitoring for guided self-management in childhood asthma: a randomized controlled trial. Am J Respir Crit Care 2004; 170: 606–612.
40. 40 Mochizuki H, Hirai K, Tabata H. Forced oscillation technique and childhood asthma. Allergol Int 2012; 61: 373–383.
41. 41 Goldman MD. Clinical application of forced oscillation. Pulm Pharmacol Ther 2001; 14: 341–350.
42. 42 Klug B, Bisgaard H. Measurement of lung function in awake 2–4-year-old asthmatic children during methacholine challenge and acute asthma: a comparison of the impulse oscillation technique, the interrupter technique, and transcutaneous measurement of oxygen versus whole-body plethysmography. Pediatr Pulmonol 1996; 21: 290–300.
43. 43 Komarow HD, Skinner J, Young M, et al. A study of the use of impulse oscillometry in the evaluation of children with asthma: analysis of lung parameters, order effect, and utility compared with spirometry. Pediatr Pulmonol 2012; 47: 18–26.
44. 44 McKenzie SA, Chan E, Dundas I, et al. Airway resistance measured by the interrupter technique: normative data for 2–10 year olds of three ethnicities. Arch Dis Child 2002; 87: 248–251.
45. 45 Merkus PJ, Mijnsbergen JY, Hop WC, et al. Interrupter resistance in preschool children: measurement characteristics and reference values. Am J Respir Crit Care Med 2001; 163: 1350–1355.
46. 46 Boccaccino A, Peroni DG, Pietrobelli A, et al. Assessment of variable obstruction by forced expiratory volume in 1 second, forced oscillometry, and interrupter technique. Allergy Asthma Proc 2007; 28: 331–335.
47. 47 Hall GL, Gangell C, Fukushima T, et al. Application of a shortened inhaled adenosine-5′-monophosphate challenge in young children using the forced oscillation technique. Chest 2009; 136: 184–189.
48. 48 Wilson NM, Bridge P, Silverman M. Bronchial responsiveness and symptoms in 5–6 year old children: a comparison of a direct and indirect challenge. Thorax 1995; 50: 339–345.
49. 49 Beydon N, M’Buila C, Bados A, et al. Interrupter resistance short-term repeatability and bronchodilator response in preschool children. Respir Med 2007; 101: 2482–2487.
50. 50 Mele L, Sly PD, Calogero C, et al. Assessment and validation of bronchodilation using the interrupter technique in preschool children. Pediatr Pulmonol 2010; 45: 633–638.
51. 51 Caudri D, Wijga AH, Hoekstra MO, et al. Prediction of asthma in symptomatic preschool children using exhaled nitric oxide, Rint and specific IgE. Thorax 2010; 65: 801–807.
52. 52 Larsen GL, Morgan W, Heldt GP, et al. Impulse oscillometry versus spirometry in a long-term study of controller therapy for pediatric asthma. J Allergy Clin Immunol 2009; 123: 861–867.
53. 53 Shi Y, Aledia AS, Galant SP, et al. Peripheral airway impairment measured by oscillometry predicts loss of asthma control in children. J Allergy Clin Immunol 2013; 131: 718–723.
54. 54 Jenkins HA, Cherniack R, Szefler SJ, et al. A comparison of the clinical characteristics of children and adults with severe asthma. Chest 2003; 124: 1318–1324.
55. 55 Labbe G, Merlin E, Kauffman C, et al. Interet de la mesure des volumes pulmonaires par plethysmographie corporelle dans le suivi de l’asthme de l’enfant [The role of lung volume measurements by plethysmography in the follow-up of asthma in children]. Rev Mal Respir 2010; 27: 42–48.
56. 56 Mahut B, Trinquart L, Bokov P, et al. Relationships between specific airway resistance and forced expiratory flows in asthmatic children. PLoS One 2009; 4: e5270.
57. 57 Mahut B, Beydon N, Delclaux C. Overweight is not a comorbidity factor during childhood asthma: the GrowthOb study. Eur Respir J 2012; 39: 1120–1126.
58. 58 Aurora P, Kozlowska W, Stocks J. Gas mixing efficiency from birth to adulthood measured by multiple-breath washout. Respir Physiol Neurobiol 2005; 148: 125–139.
59. 59 Gustafsson PM. Peripheral airway involvement in CF and asthma compared by inert gas washout. Pediatr Pulmonol 2007; 42: 168–176.
60. 60 Keen C, Olin AC, Wennergren G, et al. Small airway function, exhaled NO and airway hyper-responsiveness in paediatric asthma. Respir Med 2011; 105: 1476–1484.
61. 61 Macleod KA, Horsley AR, Bell NJ, et al. Ventilation heterogeneity in children with well controlled asthma with normal spirometry indicates residual airways disease. Thorax 2009; 64: 33–37.
62. 62 Turner SW, Young S, Goldblatt J, et al. Childhood asthma and increased airway responsiveness: a relationship that begins in infancy. Am J Respir Crit Care Med 2009; 179: 98–104.
63. 63 Moeller A, Franklin P, Hall GL, et al. Inhaled fluticasone dipropionate decreases levels of nitric oxide in recurrenty wheezy infants. Pediatr Pulmonol 2004; 38: 250–255.
64. 64 Straub DA, Moeller A, Minocchieri S, et al. The effect of montelukast on lung function and exhaled nitric oxide in infants with early childhood asthma. Eur Respir J 2005; 25: 289–294.
65. 65 Pelkonen AS, Kotaniemi-Syrjänen A, Malmström K, et al. Clinical findings associated with abnormal lung function in children aged 3–26 months with recurrent respiratory symptoms. Acta Paediatr 2010; 99: 1175–1179.
66. 66 Young S, Arnott J, O’Keeffe PT, et al. The association between early life lung function and wheezing during the first 2 yrs of life. Eur Respir J 2000; 15: 151–157.
67. 67 Håland G, Carlsen KC, Sandvik L, et al. Reduced lung function at birth and the risk of asthma at 10 years of age. N Engl J Med 2006; 355: 1682–1689.
68. 68 Martinez FD, Wright AL, Taussig LM, et al. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 1995; 332: 133–138.
69. 69 Turner SW, Palmer LJ, Rye PJ, et al. Infants with flow limitation at 4 weeks: outcome at 6 and 11 years. Am J Respir Crit Care Med 2002; 165: 1294–1298.
70. 70 Palmer LJ, Rye PJ, Gibson NA, et al. Airway responsiveness in early infancy predicts asthma, lung function, and respiratory symptoms by school age. Am J Respir Crit Care Med 2001; 163: 37–42.
71. 71 Malmström K, Pelkonen AS, Malmberg LP, et al. Lung function, airway remodelling and inflammation in symptomatic infants: outcome at 3 years. Thorax 2011; 66: 157–162.
72. 72 Murray CS, Pipis SD, McArdle EC, et al. Lung function at one month of age as a risk factor for infant respiratory symptoms in a high risk population. Thorax 2002; 57: 388–392.
73. 73 Pike KC, Rose-Zerilli MJ, Osvald EC, et al. The relationship between infant lung function and the risk of wheeze in the preschool years. Pediatr Pulmonol 2011; 46: 75–82.
74. 74 Mallol J, Aguirre V, Barrueto L, et al. Effect of inhaled fluticasone on lung function in infants with recurrent wheezing: a randomised controlled trial. Allergol Immunopathol (Madr) 2009; 37: 57–62.
75. 75 Pelkonen AS, Malmström K, Sarna S, et al. The effect of montelukast on respiratory symptoms and lung function in wheezy infants. Eur Respir J 2013; 41: 664–670.
76. 76 Aas K. Bronchial provocation tests in asthma. Arch Dis Child 1970; 45: 221–228.
77. 77 Cockcroft DW, Killian DN, Mellon JJ, et al. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy 1977; 7: 235–243.
78. 78 Hargreave FE, Ryan G, Thomson NC, et al. Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance. J Allergy Clin Immunol 1981; 68: 347–355.
79. 79 Jones RS, Wharton MJ, Buston MH. The place of physical exercise and bronchodilator drugs in the assessment of the asthmatic child. Arch Dis Child 1963; 38: 539–545.
80. 80 Zach MS, Polgar G. Cold air challenge of airway hyperreactivity in children: dose-response interrelation with a reaction plateau. J Allergy Clin Immunol 1987; 80: 9–17.
81. 81 Rosenthal RR. Simplified eucapnic voluntary hyperventilation challenge. J Allergy Clin Immunol 1984; 73: 676–679.
82. 82 Avital A, Springer C, Bar-Yishay E, et al. Adenosine, methacholine, and exercise challenges in children with asthma or paediatric chronic obstructive pulmonary disease. Thorax 1995; 50: 511–516.
83. 83 Brannan JD, Anderson SD, Perry CP, et al. The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: a phase 3 comparison study with hypertonic (4.5%) saline. Respir Res 2005; 6: 144.
84. 84 Yan K, Salome C, Woolcock AJ. Rapid method for measurement of bronchial responsiveness. Thorax 1983; 38: 760–765.
85. 85 Alblooshi AS, Simpson SJ, Stick SM, et al. The safety and feasibility of the inhaled mannitol challenge test in young children. Eur Respir J 2013; 42: 1420–1423.
86. 86 Stensrud T, Berntsen S, Carlsen KH. Exercise capacity and exercise-induced bronchoconstriction (EIB) in a cold environment. Respir Med 2007; 101: 1529–1536.
87. 87 Stensrud T, Berntsen S, Carlsen KH. Humidity influences exercise capacity in subjects with exercise-induced bronchoconstriction (EIB). Respir Med 2006; 100: 1633–1641.
88. 88 Carlsen KH, Engh G, Mørk M. Exercise-induced bronchoconstriction depends on exercise load. Respir Med 2000; 94: 750–755.
89. 89 Anderson SD, Silverman M, Tai E, et al. Specificity of exercise in exercise-induced asthma. Br Med J 1971; 4: 814–815.
90. 90 Godfrey S, Silverman M, Anderson SD. The use of the treadmill for assessing exercise-induced asthma and the effect of varying the severity and duration of exercise. Pediatrics 1975; Suppl., 56: 893–898.
91. 91 Carlsen KH, Engh G, Mørk M, et al. Cold air inhalation and exercise-induced bronchoconstriction in relationship to metacholine bronchial responsiveness: different patterns in asthmatic children and children with other chronic lung diseases. Respir Med 1998; 92: 308–315.
92. 92 Henriksen JM, Dahl R. Effects of inhaled budesonide alone and in combination with low-dose terbutaline in children with exercise-induced asthma. Am Rev Respir Dis 1983; 128: 993–997.
93. 93 van Essen-Zandvliet EE, Hughes MD, Waalkens HJ, et al. Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group. Am Rev Respir Dis 1992; 146: 547–554.
94. 94 Nuijsink M, Hop WC, Sterk PJ, et al. Long-term asthma treatment guided by airway hyperresponsiveness in children: a randomised controlled trial. Eur Respir J 2007; 30: 457–466.
95. 95 Riiser A, Hovland V, Carlsen KH, et al. Does bronchial hyperresponsiveness in childhood predict active asthma in adolescence? Am J Respir Crit Care Med 2012; 186: 493–500.
96. 96 Hagmolen Of Ten Have W, van den Berg NJ, van der Palen J, et al. Severe airway hyperresponsiveness was not predictable with the use of current tools in asthmatic children in general practice. J Clin Epidemiol 2007; 60: 1052–1059.
97. 97 De Baets F, Bodart E, Dramaix-Wilmet M, et al. Exercise-induced respiratory symptoms are poor predictors of bronchoconstriction. Pediatr Pulmonol 2005; 39: 301–305.
98. 98 American Thoracic Society, European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005; 171: 912–930.
99. 99 Boot JD, de Ridder L, de Kam ML, et al. Comparison of exhaled nitric oxide measurements between NIOX MINO electrochemical and Ecomedics chemiluminescence analyzer. Respir Med 2008; 102: 1667–1671.
100. 100 Kalliola S, Malmberg P, Rito T, et al. Can we use portable nitric oxide analyzer in young children? Pediatr Pulmonol 2011; 46: 627–631.
101. 101 McGill C, Malik G, Turner SW. Validation of a hand-held exhaled nitric oxide analyzer for use in children. Pediatr Pulmonol 2006; 41: 1053–1057.
102. 102 Schiller B, Hammer J, Barben J, et al. Comparability of a hand-held nitric oxide analyser with online and offline chemiluminescence-based nitric oxide measurement. Pediatr Allergy Immunol 2009; 20: 679–685.
103. 103 Takalo R, Piirilä P, Sovijärvi AR. Repeatability of successive measurements with a portable nitric oxide analyser in patients with suggested or diagnosed asthma. Scand J Clin Lab Invest 2008; 68: 830–832.
104. 104 Buchvald F, Baraldi E, Carraro S, et al. Measurements of exhaled nitric oxide in healthy subjects age 4 to 17 years. J Allergy Clin Immunol 2005; 115: 1130–1136.
105. 105 Malmberg LP, Petäys T, Haahtela T, et al. Exhaled nitric oxide in healthy nonatopic school-age children: determinants and height-adjusted reference values. Pediatr Pulmonol 2006; 41: 635–642.
106. 106 Vijverberg SJ, Koster ES, Koenderman L, et al. Exhaled NO is a poor marker of asthma control in children with a reported use of asthma medication: a pharmacy-based study. Pediatr Allergy Immunol 2012; 23: 529–536.
107. 107 Malmberg LP, Pelkonen AS, Mattila PS, et al. Exhaled nitric oxide and exercise-induced bronchoconstriction in young wheezy children –interactions with atopy. Pediatr Allergy Immunol 2009; 20: 673–678.
108. 108 Pijnenburg MW, Hofhuis W, Hop WC, et al. Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission. Thorax 2005; 60: 215–218.
109. 109 Zacharasiewicz A, Wilson N, Lex C, et al. Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children. Am J Respir Crit Care Med 2005; 171: 1077–1082.
110. 110 Visser CA, Brand PL. Does a single measurement of exhaled nitric oxide predict asthma exacerbations? Arch Dis Child 2011; 96: 781–782.
111. 111 Cabral AL, Vollmer WM, Barbirotto RM, et al. Exhaled nitric oxide as a predictor of exacerbation in children with moderate-to-severe asthma: a prospective, 5-month study. Ann Allergy Asthma Immunol 2009; 103: 206–211.
112. 112 Pijnenburg MW, Bakker EM, Hop WC, et al. Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial. Am J Respir Crit Care Med 2005; 172: 831–836.
113. 113 Fritsch M, Uxa S, Horak F Jr, et al. Exhaled nitric oxide in the management of childhood asthma: a prospective 6-months study. Pediatr Pulmonol 2006; 41: 855–862.
114. 114 Szefler SJ, Mitchell H, Sorkness CA, et al. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. Lancet 2008; 372: 1065–1072.
115. 115 de Jongste JC, Carraro S, Hop WC, et al. Daily telemonitoring of exhaled nitric oxide and symptoms in the treatment of childhood asthma. Am J Respir Crit Care Med 2009; 179: 93–97.
116. 116 Fuchs O, Latzin P, Thamrin C, et al. Normative data for lung function and exhaled nitric oxide in unsedated healthy infants. Eur Respir J 2011; 37: 1208–1216.
117. 117 Malmberg LP, Pelkonen AS, Haahtela T, et al. Exhaled nitric oxide rather than lung function distinguishes preschool children with probable asthma. Thorax 2003; 58: 494–499.
118. 118 Sonnappa S, Bastardo CM, Wade A, et al. Symptom-pattern phenotype and pulmonary function in preschool wheezers. J Allergy Clin Immunol 2010; 126: 519–526.
119. 119 Baraldi E, Dario C, Ongaro R, et al. Exhaled nitric oxide concentrations during treatment of wheezing exacerbation in infants and young children. Am J Respir Crit Care Med 1999; 159: 1284–1288.
120. 120 Moeller A, Franklin P, Hall GL, et al. Measuring exhaled breath condensates in infants. Pediatr Pulmonol 2006; 41: 184–187.
121. 121 Oh JW, Lee HB, Kim CR, et al. Analysis of induced sputum to examine the effects of inhaled corticosteroid on airway inflammation in children with asthma. Ann Allergy Asthma Immunol 1999; 82: 491–496.
122. 122 Kaptein AA, Hughes BM, Scharloo M, et al. Illness perceptions about asthma are determinants of outcome. J Asthma 2008; 45: 459–464.
123. 123 Singer F, Luchsinger I, Inci D, et al. Exhaled nitric oxide in symptomatic children at preschool age predicts later asthma. Allergy 2013; 68: 531–538.
124. 124 Moeller A, Diefenbacher C, Lehmann A, et al. Exhaled nitric oxide distinguishes between subgroups of preschool children with respiratory symptoms. J Allergy Clin Immunol 2008; 121: 705–709.
125. 125 Debley JS, Stamey DC, Cochrane ES, et al. Exhaled nitric oxide, lung function, and exacerbations in wheezy infants and toddlers. J Allergy Clin Immunol 2010; 125: 1228–1234.
126. 126 Chawes BL, Buchvald F, Bischoff AL, et al. Elevated exhaled nitric oxide in high-risk neonates precedes transient early but not persistent wheeze. Am J Respir Crit Care Med 2010; 182: 138–142.
127. 127 Kotaniemi-Syrjänen A, Malmberg LP, Malmström K, et al. Factors associated with elevated exhaled nitric oxide fraction in infants with recurrent respiratory symptoms. Eur Respir J 2013; 41: 189–194.
128. 128 Moeller A, Lehmann A, Knauer N, et al. Effects of montelukast on subjective and objective outcome measures in preschool asthmatic children. Pediatr Pulmonol 2008; 43: 179–186.
129. 129 Gibson PG, Grootendor DC, Henry RL, et al. Sputum induction in children. Eur Respir J 2002; 20: Suppl. 37, 44s–46s.
130. 130 Fleming L, Wilson N, Regamey N, et al. Use of sputum eosinophil counts to guide management in children with severe asthma. Thorax 2012; 67: 193–198.
131. 131 Lex C, Payne DN, Zacharasiewicz A, et al. Sputum induction in children with difficult asthma: safety, feasibility, and inflammatory cell pattern. Pediatr Pulmonol 2005; 39: 318–324.
132. 132 Li AM, Tsang TW, Lam HS, et al. Predictors for failed dose reduction of inhaled corticosteroids in childhood asthma. Respirology 2008; 13: 400–407.
133. 133 Lex C, Jenkins G, Wilson NM, et al. Does sputum eosinophilia predict the response to systemic corticosteroids in children with difficult asthma? Pediatr Pulmonol 2007; 42: 298–303.
134. 134 Baraldi E, Ghiro L, Piovan V, et al. Safety and success of exhaled breath condensate collection in asthma. Arch Dis Child 2003; 88: 358–360.
135. 135 Thomas PS, Lowe AJ, Samarasinghe P, et al. Exhaled breath condensate in pediatric asthma: promising new advance or pouring cold water on a lot of hot air? A systematic review. Pediatr Pulmonol 2013; 48: 419–442.
136. 136 Sinha A, Krishnan V, Sethi T, et al. Metabolomic signatures in nuclear magnetic resonance spectra of exhaled breath condensate identify asthma. Eur Respir J 2012; 39: 500–502.
137. 137 Horváth I, Hunt J, Barnes PJ, et al. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 2005; 26: 523–548.
138. 138 van de Kant KD, Klaassen EM, Jöbsis Q, et al. Wheezing in preschool children is associated with increased levels of cytokines/chemokines in exhaled breath condensate. J Allergy Clin Immunol 2010; 126: 669–671.
139. 139 von Jagwitz M, Pessler F, Akmatov M, et al. Reduced breath condensate pH in asymptomatic children with prior wheezing as a risk factor for asthma. J Allergy Clin Immunol 2011; 128: 50–55.
140. 140 Rosias PP, Robroeks CM, van de Kant KD, et al. Feasibility of a new method to collect exhaled breath condensate in pre-school children. Pediatr Allergy Immunol 2010; 21: e235–e244.
141. 141 Zanconato S, Carraro S, Corradi M, et al. Leukotrienes and 8-isoprostane in exhaled breath condensate of children with stable and unstable asthma. J Allergy Clin Immunol 2004; 113: 257–263.
142. 142 Trischler J, Merkel N, Konitzer S, et al. Fractionated breath condensate sampling: H2O2 concentrations of the alveolar fraction may be related to asthma control in children. Respir Res 2012; 13: 14.
143. 143 Robroeks CM, van de Kant KD, Jöbsis Q, et al. Exhaled nitric oxide and biomarkers in exhaled breath condensate indicate the presence, severity and control of childhood asthma. Clin Exp Allergy 2007; 37: 1303–1311.
144. 144 Kostikas K, Papaioannou AI, Tanou K, et al. Exhaled NO and exhaled breath condensate pH in the evaluation of asthma control. Respir Med 2011; 105: 526–532.
145. 145 Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008; 31: 143–178.
146. 146 Kostikas K, Papatheodorou G, Ganas K, et al. PH in expired breath condensate of patients with inflammatory airway diseases. Am J Respir Crit Care Med 2002; 165: 1364–1370.
147. 147 Hunt JF, Fang K, Malik R, et al. Endogenous airway acidification. Implications for asthma pathophysiology. Am J Respir Crit Care Med 2000; 161: 694–699.